World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
75
Citations
19832
World Ranking
1195
National Ranking
619

Overview

Julia A. Bridge is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in various subfields including Pulmonary and Respiratory Medicine, Rheumatology, Surgery, Oncology, and Molecular Biology.

The scientific work covers several main topics in biomedical research, notably:

  • Sarcoma Diagnosis and Treatment
  • Soft tissue tumor case studies
  • Histiocytic Disorders and Treatments
  • Cancer and Skin Lesions
  • Urologic and reproductive health conditions
  • Cardiac tumors and thrombi
  • Tumors and Oncological Cases

Julia A. Bridge has contributed to multiple recent papers, including:

  • EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma (2021, Modern Pathology)
  • Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria (2020, European Urology Oncology)
  • Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck (2021, The American Journal of Surgical Pathology)
  • Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion (2020, Modern Pathology)
  • Inflammatory and Nested Testicular Sex Cord Tumor (2023, The American Journal of Surgical Pathology)

The frequent coauthors collaborating with Julia A. Bridge include:

  • Jiancong Liang
  • Konstantinos Linos
  • Frank Mezzacappa
  • Andrew Gard
  • Fatmagül Çabuk

Publications often appear in several key research venues where Julia A. Bridge is a recurring contributor:

  • Graduate Medical Education Research Journal
  • Journal of Cutaneous Pathology
  • Modern Pathology
  • Cancer Genetics
  • Genes Chromosomes and Cancer

Best Publications

  • A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer

    David L. Rimm;Gang Han;Janis M. Taube;Eunhee S. Yi

  • The der(17)t(x;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Marc Ladanyi;Man Yee Lui;Cristina R Antonescu;Amber Krause-Boehm

  • Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor

    Julia A. Bridge;Masahiko Kanamori;Zhigui Ma;Diane Pickering

  • Renal carcinomas with the t(6;11)(p21;q12): Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR

    Pedram Argani;Marick Laé;Brian Hutchinson;Victor E. Reuter

  • USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst

    Andre M. Oliveira;Andre M. Oliveira;Bae Li Hsi;Stanislawa Weremowicz;Andrew E. Rosenberg

  • Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data

    Lu Wang;Toru Motoi;Raya Khanin;Adam Olshen

  • Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.

    Zhigui Ma;D. Ashley Hill;Margaret H. Collins;Stephan W. Morris

  • Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.

    Larisa V Debelenko;Susana C Raimondi;Najat Daw;Bangalore R Shivakumar

  • Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes

    Andre M. Oliveira;Andre M. Oliveira;Antonio R. Perez-Atayde;Paola Dal Cin;Mark C. Gebhardt

  • Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts).

    Unknown

  • The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.

    Dong Fang;Haiyun Gan;Jeong Heon Lee;Jing Han

  • Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution

    Roland P. Kuiper;Marga Schepens;José Thijssen;Martien van Asseldonk

  • Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature

    Unknown

  • Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.

    Frederic G. Barr;Stephen J. Qualman;Michele H. Macris;Natalya Melnyk

  • ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)

    Gisele W.B. Colleoni;Julia A. Bridge;Bernardo Garicochea;Jian Liu

  • Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma

    Unknown

  • Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.

    Janos Sumegi;Renae Streblow;Robert W. Frayer;Paola Dal Cin

  • Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.

    Jane Bayani;Maria Zielenska;Ajay Pandita;Khaldoun Al-Romaih

  • Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study.

    Julia A. Bridge;Jian Liu;Vines Weibolt;Vines Weibolt;K. Scott Baker

  • Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes

    Julia A. Bridge;Jian Liu;Stephen J. Qualman;Stephen J. Qualman;Ron Suijkerbuijk;Ron Suijkerbuijk

Frequent Co-Authors

Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
David M. Parham
David M. Parham Children's Hospital of Los Angeles
Warren G. Sanger
Warren G. Sanger University of Nebraska Medical Center
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center
Paola Dal Cin
Paola Dal Cin Harvard Medical School
Jonathan A. Fletcher
Jonathan A. Fletcher Brigham and Women's Hospital
Avery A. Sandberg
Avery A. Sandberg Roswell Park Cancer Institute
Fredrik Mertens
Fredrik Mertens Lund University
Pedram Argani
Pedram Argani Johns Hopkins University
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your knowledge in Molecular Biology can open doors to various online degree options and flexible career pathways in the USA. Many students explore programs offered by a non profit online university, ensuring quality education and recognized accreditation. These institutions often provide robust support services and flexible online formats.

For veterans or active military personnel, there are also dedicated military friendly online colleges that understand the unique needs of service members and offer resources tailored to support their academic journeys.

Related fields, such as healthcare, social sciences, and psychology, are accessible through online programs as well. You might consider an online masters of social work for a clinical or community-oriented career, or explore accelerated masters psychology programs for fast-tracked entry into behavioral health roles.

With the convenience of online education, pursuing these degrees can enhance your expertise, broaden your career prospects, and allow you to make an impact in science, healthcare, and allied fields.

Best Scientists Citing Julia A. Bridge

Trending Scientists

Recently Published Articles